ALS Centre CHU Bretonneau

Care Missions

  1. Consultation of recourse for MND
  2. Management of MND patients from diagnosis to last stages
  3. Quaterly Multidisciplinary follow-up of MND patients
  4. Coordonation of  medical, paramedical and social support at home in collaboration with the NeuroCentre Networ

Research

Genetics

  • Identification of susceptibility factors of ALS
  • Setup of next generation sequencing

Biomarkers

  • Identification of CSF and blood biomarkers for the diagnostic and the pronostic of ALS using metabolomics
  • Energetic metabolism exploration (calorimetry, functional exploration of fibroblasts…) : ongoing

Clinical Trials

  1. Contribution to clinical trials
  2. Development of pharmacogenomics

We are also developing scientific projects on Molecular Imaging focused on neuro-inflammation.

We are setting-up a ALS Registry in the Centre Val de Loire which is an extension of the Registry of the Limousin

Communications and Publications of the results of our studies during French and International ALS Meeting and into national and international reviews.

ALS Centre CHU Bretonneau
Foundation year

2003

Director

Prof. Philippe Corcia

Principal investigator

Prof. Philippe Corcia

Contact information
Address

ALS Centre
Neurology Departement
CHU Bretonneau
2 Boulevard Tonnellé
37044 Tours CEDEX1, France

Contact

Prof. Philippe Corcia

Phone

+33247474747 ext 70332. Secretary: +33247473724

Email corcia@med.univ-tours.fr

Publications

Restricted information

Patient resources
Population based register

No

Clinic based register

Yes

Geographically matched controls

Yes

Banks

Type ALS Patients Controls Other
DNA bank 1000 400
Serum bank 50 30
RNA bank
LCR bank 50 100
Muscle bank 10 20
Research activities
Clinical management research

No

Neuro epidemiology

Yes

Neuro physiology

No

Neuro imaging

No

Neuro psychology

No

Neuro pathology

No

Genomics

Yes

Transcriptomics

No

Metabolomics

Yes

Clinical Trials - Industry sponsored

Name Type Patients
Cy4031 Therapeutic
MIROCALS (in process)
TUDCA-H2020 (in process)
ROCK-ALS (in process)

Clinical Trials - Investigator initiated

Name Type Patients
Pulse Observational 1
NUTRALS Therapeutic 18